IL149256A0 - Resolution of intermediates in the synthesis of substantially pure bicalutamide - Google Patents

Resolution of intermediates in the synthesis of substantially pure bicalutamide

Info

Publication number
IL149256A0
IL149256A0 IL14925600A IL14925600A IL149256A0 IL 149256 A0 IL149256 A0 IL 149256A0 IL 14925600 A IL14925600 A IL 14925600A IL 14925600 A IL14925600 A IL 14925600A IL 149256 A0 IL149256 A0 IL 149256A0
Authority
IL
Israel
Prior art keywords
intermediates
resolution
synthesis
substantially pure
pure bicalutamide
Prior art date
Application number
IL14925600A
Other languages
English (en)
Original Assignee
Nobex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobex Corp filed Critical Nobex Corp
Publication of IL149256A0 publication Critical patent/IL149256A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/06Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14925600A 1999-10-27 2000-10-25 Resolution of intermediates in the synthesis of substantially pure bicalutamide IL149256A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16188499P 1999-10-27 1999-10-27
PCT/US2000/041609 WO2001034563A1 (en) 1999-10-27 2000-10-25 Resolution of intermediates in the synthesis of substantially pure bicalutamide

Publications (1)

Publication Number Publication Date
IL149256A0 true IL149256A0 (en) 2002-11-10

Family

ID=22583193

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14925600A IL149256A0 (en) 1999-10-27 2000-10-25 Resolution of intermediates in the synthesis of substantially pure bicalutamide
IL149256A IL149256A (en) 1999-10-27 2002-04-22 Resolution of intermediates in the synthesis of essentially pure bicalotamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149256A IL149256A (en) 1999-10-27 2002-04-22 Resolution of intermediates in the synthesis of essentially pure bicalotamide

Country Status (19)

Country Link
US (1) US6593492B1 (cs)
EP (1) EP1224167A1 (cs)
JP (1) JP4778178B2 (cs)
KR (1) KR20020067509A (cs)
CN (1) CN1413188A (cs)
AU (1) AU2619501A (cs)
BR (1) BR0015124A (cs)
CA (1) CA2389100A1 (cs)
CZ (1) CZ20021434A3 (cs)
HK (1) HK1048299A1 (cs)
HU (1) HUP0203186A2 (cs)
IL (2) IL149256A0 (cs)
MX (1) MXPA02004225A (cs)
NO (1) NO20021999L (cs)
NZ (1) NZ518552A (cs)
PL (1) PL360059A1 (cs)
TW (1) TWI271397B (cs)
WO (1) WO2001034563A1 (cs)
ZA (1) ZA200203228B (cs)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995284B2 (en) 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6071957A (en) 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US6998500B2 (en) 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8445534B2 (en) 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
US6838484B2 (en) 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US8008348B2 (en) 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US7026500B2 (en) 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
CA2448571A1 (en) * 2001-06-13 2002-12-19 Biogal Gyogyszergyar Rt. Novel process for preparing rac-bicalutamide and its intermediates
BR0215115A (pt) 2001-12-06 2005-04-19 Gtx Inc Tratamento de perda muscular com moduladores de receptores de androgênio seletivos
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
DE60233526D1 (de) 2001-12-13 2009-10-08 Sumitomo Chemical Co Bicalutamidkristalle und verfahren zu deren herstellung
CA2689080C (en) 2002-02-07 2011-07-05 University Of Tennessee Research Foundation Treating benign prostate hyperplasia with sarms
WO2003074450A2 (en) 2002-02-28 2003-09-12 The University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
US7772433B2 (en) 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
EP1487458B1 (en) 2002-02-28 2011-11-16 University Of Tennessee Research Foundation Multi-substituted selective androgen receptor modulators and methods of use thereof
US7803970B2 (en) 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
US7741371B2 (en) 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
BR0312172A (pt) 2002-06-17 2005-04-05 Univ Tennessee Res Foundation Moduladores seletivos receptores de androgênio em ponte de nitrogênio e seus métodos de uso
US6818766B2 (en) 2002-10-02 2004-11-16 Synthon Bv Process for making bicalutamide and intermediates thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
EP1669347A1 (en) * 2004-12-10 2006-06-14 Helm AG Process for the preparation of 3-¬(4-fluorophenyl) sulfonyl|-2-hydroxy-2-methyl propionic acid
US20060269596A1 (en) * 2005-01-12 2006-11-30 Gary Liversidge Controlled release compositions comprising an acylanilide
WO2006103689A1 (en) * 2005-03-29 2006-10-05 Usv Limited Process for preparation of bicalutamide
WO2008013791A2 (en) * 2006-07-24 2008-01-31 University Of Delaware Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
PT2054049E (pt) 2006-08-24 2016-06-02 Univ Tennessee Res Found Acilanilidas substituídas e métodos de utilização das mesmas
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
WO2011008543A2 (en) * 2009-06-29 2011-01-20 University Of Delaware Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal
WO2012042532A1 (en) 2010-09-29 2012-04-05 Shilpa Medicare Limited Process for preparing bicalutamide
CN103539710A (zh) * 2012-07-02 2014-01-29 国药一心制药有限公司 一种(r)-比卡鲁胺的合成方法
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
RU2648959C2 (ru) 2012-07-13 2018-03-28 Джи Ти Икс, ИНК. Способ лечения андроген-рецептора(ar)-положительных форм рака молочной железы с использованием селективных модуляторов андрогенных рецепторов(sarm)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
CN104897818A (zh) * 2015-06-19 2015-09-09 重庆医药高等专科学校 一种同时测定比卡鲁胺中6种有关物质的uplc方法
CN108069887B (zh) * 2016-11-17 2021-04-20 山西振东制药股份有限公司 一种(r)-比卡鲁胺中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58183669A (ja) * 1982-04-19 1983-10-26 Teikoku Chem Ind Corp Ltd 光学活性なプロピオン酸誘導体の製造方法
LU88769I2 (fr) * 1982-07-23 1996-11-05 Zeneca Ltd Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
GB8617652D0 (en) * 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
WO1994008986A1 (en) 1992-10-21 1994-04-28 Pfizer, Inc. Enantiomeric cis-3-(4,6-dihydroxychroman-3-yl-methyl)benzoic acids
CA2181358A1 (en) * 1994-01-21 1995-07-27 Nancy M. Gray Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
AU7723198A (en) 1997-06-04 1998-12-21 University Of Tennessee Research Corporation, The Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging

Also Published As

Publication number Publication date
MXPA02004225A (es) 2002-10-17
AU2619501A (en) 2001-06-06
CN1413188A (zh) 2003-04-23
JP2003513955A (ja) 2003-04-15
ZA200203228B (en) 2003-07-23
HUP0203186A2 (hu) 2003-01-28
WO2001034563A1 (en) 2001-05-17
CA2389100A1 (en) 2001-05-17
TWI271397B (en) 2007-01-21
BR0015124A (pt) 2002-07-02
EP1224167A1 (en) 2002-07-24
NO20021999D0 (no) 2002-04-26
HK1048299A1 (zh) 2003-03-28
CZ20021434A3 (cs) 2002-11-13
NO20021999L (no) 2002-06-20
JP4778178B2 (ja) 2011-09-21
NZ518552A (en) 2003-10-31
IL149256A (en) 2011-05-31
PL360059A1 (en) 2004-09-06
US6593492B1 (en) 2003-07-15
KR20020067509A (ko) 2002-08-22

Similar Documents

Publication Publication Date Title
IL149256A0 (en) Resolution of intermediates in the synthesis of substantially pure bicalutamide
EG24138A (en) Asymmetrics synthesis of pregabalin
IL149592A0 (en) Synthesis of 2'-deoxy-l-nucleosides
IL214165A0 (en) Intermediates useful in the synthesis of statin derivatives
EG21992A (en) Ester synthesis
GB9909756D0 (en) Synthesis of polycarbonates
GB9819973D0 (en) Improvements relating to beamformers
AU7918200A (en) Oxidation process for the preparation of intermediates useful in the synthesis of diarylpyridines
EP1218407A4 (en) USES OF KAPPA-CONOTOXIN PVIIA
AU2402600A (en) Pentafulvene synthesis
MXPA01009617A (es) Sisntesis de propanoatos de 3-amino-3-arilo.
GB9815117D0 (en) Ester synthesis
GB0002333D0 (en) Compound synthesis
AU1695901A (en) Process for the preparation of intermediates useful in the synthesis of diarylpyridines
GB0011407D0 (en) Synthesis of substituted prolines
AU2002360409A8 (en) Methods and intermediates for the synthesis of azepines
GB0225106D0 (en) Synthesis of 3 hydroxy-5 -steroids
IL137918A0 (en) Solid support synthesis of 2-oxopiperazines
HUP0103105A3 (en) Process for the synthesis of exochelins
GB9917115D0 (en) ›-lactone synthesis
GB9921408D0 (en) Rapid synthesis of manganite compounds
HUP0200746A3 (en) Novel intermediate for the synthesis of prostaglandins and process for its preparation
GB9800464D0 (en) Efficient synthesis of cycloproplacetylene
IL137917A0 (en) Solid phase synthesis of 1-aminohydantoins
AU2001259381A1 (en) Synthesis of diphosphinoarenes